Temporary Regulatory Deviations and the Coronavirus Disease 2019 (COVID-19) PCR Labeling Update Study Indicate What Laboratory-Developed Test Regulation by the US Food and Drug Administration (FDA) Could Look Like
Author:
Funder
NCI
National Institutes of Health
Publisher
Elsevier BV
Subject
Molecular Medicine,Pathology and Forensic Medicine
Reference60 articles.
1. Deadly delay: the FDA’s role in America’s COVID-19 testing debacle;Evans;Yale LJF,2020
2. Legislating in the time of a pandemic: window of opportunity or invitation for recklessness?;Johnson;J L Biosci,2020
3. One year later: what have we learned from COVID-19? lessons and accomplishments in academic pathology departments;Kaul;Acad Pathol,2021
4. Covid-19 molecular diagnostic testing - lessons learned;Shuren;N Engl J Med,2020
5. Laboratory-developed tests are not the practice of medicine;Allen;MLO Med Lab Obs,2015
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML;Clinical Chemistry and Laboratory Medicine (CCLM);2023-01-25
2. Laboratory-Developed Tests in the New European Union 2017/746 Regulation: Opportunities and Risks;Clinical Chemistry;2021-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3